z-logo
open-access-imgOpen Access
Next-Generation Continuous Metabolite Sensing toward Emerging Sensor Needs
Author(s) -
Ashlesha Bhide,
Antra Ganguly,
Tejasvi Parupudi,
Mohanraj Ramasamy,
Sriram Muthukumar,
Shalini Prasad
Publication year - 2021
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.0c06209
Subject(s) - wearable computer , health care , boom , big data , computer science , resource (disambiguation) , data science , point of care , internet of things , engineering , medicine , internet privacy , pathology , computer network , environmental engineering , embedded system , operating system , economics , economic growth
This article discusses the emergent biosensor technology focused on continuous biosensing of metabolites by non-invasive sampling of body fluids emphasized on physiological monitoring in mobility-constrained populations, resource-challenged settings, and harsh environments. The boom of innovative ideas and endless opportunities in healthcare technologies has transformed traditional medicine into a sustainable link between medical practitioners and patients to provide solutions for faster disease diagnosis. The future of healthcare is focused on empowering users to manage their own health. The confluence of big data and predictive analysis and the internet of things (IoT) technology have shown the potential of converting the abundant health profile data amassed from medical diagnosis of patients into useable information, whilst allowing caregivers to provide suitable treatment plans. The implementation of the IoT technology has opened up advanced approaches in real-time, continuous, remote monitoring of patients. Wearable, point-of-care biosensors are the future roadmap to providing direct, real-time information of health status to the user and medical professionals in this digitized era.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here